Hi, I'm Lewis! My background is in Physics, but I have now pivoted from quarks to antibodies as a PhD student within the Oxford Protein Informatics Group (OPIG). I started my PhD in 2020 through the SABS CDT program and I am funded by BBSRC.

My research focuses on applying structure-based Deep Learning methods to predict antibody-antigen binding interfaces. The goal of such work is to reduce our reliance on traditional experimental techniques, thereby speeding up and reducing the cost of therapeutic antibody development.